First part of Phase-1 of Covaxin human trial completed at PGI Rohtak, results encouraging
The clinical trials of India's COVID-19 vaccine candidate — Covaxin — started all around the country in different institutes including PGI, Rohtak. As per the news agency ANI, part 1 of the first phase of trials has been completed at the Post-Graduate Institute of Medical Sciences, Rohtak.
The principal investigator of the vaccine trial team, Dr Savita Verma, said that 6 people were given the vaccine as a part 2 of the clinical trials phase 1, on Saturday. The trials started on July 17 at Rohtak. Three volunteers were given the vaccine at that time.
"First part of phase-1 of vaccine trial (Covaxin) has been completed. 50 people across India were administered the vaccine and the results were encouraging,” she said.